28458-45-9 Usage
Description
N-tert-Butyl-2-nitroaniline is an organic compound with the molecular formula C10H14N2O2. It is a derivative of aniline, featuring a tert-butyl group and a nitro group attached to the benzene ring. N-tert-Butyl-2-nitroaniline is known for its chemical reactivity and is often utilized in the synthesis of various pharmaceutical compounds.
Uses
Used in Pharmaceutical Industry:
N-tert-Butyl-2-nitroaniline is used as a reactant for the preparation of benzimidazol-2-ones. These benzimidazol-2-ones are potent, selective, and orally efficacious norepinephrine reuptake inhibitors. They play a crucial role in the development of medications targeting conditions such as attention deficit hyperactivity disorder (ADHD) and depression, where the regulation of norepinephrine levels in the brain is essential for symptom management.
Check Digit Verification of cas no
The CAS Registry Mumber 28458-45-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,4,5 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 28458-45:
(7*2)+(6*8)+(5*4)+(4*5)+(3*8)+(2*4)+(1*5)=139
139 % 10 = 9
So 28458-45-9 is a valid CAS Registry Number.
28458-45-9Relevant articles and documents
Molecular Scissors for Tailor-Made Modification of Siloxane Scaffolds
Bauer, Jonathan O.,Falk, Alexander,G?tz, Tobias
supporting information, (2021/12/09)
The controlled design of functional oligosiloxanes is an important topic in current research. A consecutive Si?O?Si bond cleavage/formation using siloxanes that are substituted with 1,2-diaminobenzene derivatives acting as molecular scissors is presented.
CRBN LIGANDS AND USES THEREOF
-
Paragraph 00509-00511, (2019/08/20)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
GSK-3BETA INHIBITOR
-
Page/Page column 1, (2011/04/13)
For the purpose of providing a GSK-3β inhibitor containing a 2-aminopyridine compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (IA): wherein each symbol is as defined in the specification. or a salt thereof or a prodrug thereof.